ARTICLE | Clinical News
Aplenzin bupropion hydrobromide regulatory update
April 28, 2008 7:00 AM UTC
FDA approved an NDA from Biovail for once-daily Aplenzin bupropion hydrobromide (formerly BVF-033) to treat depression in adults. Biovail had received a not approvable letter for the compound last Jul...